keep away from direct sunlight,store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 35.00 | |
10 mg | In stock | $ 52.00 | |
25 mg | In stock | $ 81.00 | |
50 mg | In stock | $ 117.00 | |
100 mg | In stock | $ 173.00 | |
500 mg | In stock | $ 433.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. |
Targets&IC50 | Aromatic-L-amino-acid decarboxylase:29 μM |
Synonyms | (S)-(-)-Carbidopa, Lodosyn |
Molecular Weight | 226.23 |
Formula | C10H14N2O4 |
CAS No. | 28860-95-9 |
keep away from direct sunlight,store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.5 mg/mL (20 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Carbidopa 28860-95-9 Immunology/Inflammation Metabolism Others Decarboxylase Aryl Hydrocarbon Receptor peripheral disease AhR cancer Parkinson's pancreatic Inhibitor (S)-(-)-Carbidopa Lodosyn inhibit inhibitor